- Home
- VALN vs ECPG Comparison
VALN vs ECPG Comparison
Compare VALN & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- ECPG
- Stock Information
- Founded
- VALN 2012
- ECPG 1998
- Country
- VALN France
- ECPG United States
- Employees
- VALN N/A
- ECPG N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- ECPG Finance Companies
- Sector
- VALN Health Care
- ECPG Finance
- Exchange
- VALN Nasdaq
- ECPG Nasdaq
- Market Cap
- VALN 777.9M
- ECPG 905.2M
- IPO Year
- VALN 2021
- ECPG 1999
- Fundamental
- Price
- VALN $10.71
- ECPG $40.66
- Analyst Decision
- VALN Strong Buy
- ECPG Strong Buy
- Analyst Count
- VALN 4
- ECPG 3
- Target Price
- VALN $15.75
- ECPG $62.67
- AVG Volume (30 Days)
- VALN 78.1K
- ECPG 316.5K
- Earning Date
- VALN 11-06-2025
- ECPG 11-05-2025
- Dividend Yield
- VALN N/A
- ECPG N/A
- EPS Growth
- VALN N/A
- ECPG N/A
- EPS
- VALN N/A
- ECPG N/A
- Revenue
- VALN $230,566,060.00
- ECPG $1,467,587,000.00
- Revenue This Year
- VALN $15.69
- ECPG $27.55
- Revenue Next Year
- VALN $22.15
- ECPG $5.84
- P/E Ratio
- VALN N/A
- ECPG N/A
- Revenue Growth
- VALN 25.47
- ECPG 15.50
- 52 Week Low
- VALN $3.62
- ECPG $26.45
- 52 Week High
- VALN $12.25
- ECPG $51.77
- Technical
- Relative Strength Index (RSI)
- VALN 53.86
- ECPG 40.29
- Support Level
- VALN $9.70
- ECPG $40.29
- Resistance Level
- VALN $12.23
- ECPG $42.20
- Average True Range (ATR)
- VALN 0.44
- ECPG 1.40
- MACD
- VALN 0.04
- ECPG -0.56
- Stochastic Oscillator
- VALN 34.78
- ECPG 4.16
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.